Atosiban Impurity F is a defined related substance formed during atosiban synthesis or degradation. Structural deviations modify conformational preferences and chromatographic retention. Researchers use it to validate specificity in analytical methods and to understand degradation pathways. Applications include impurity profiling, stability testing, and peptide-process optimization.
CAT No: Z10-101-221
Synonyms/Alias:(5-amino-2-((S)-1-(((R)-3-(4-ethoxyphenyl)-2-(3-mercaptopropanamido)propanoyl)-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl)pyrrolidine-2-carboxamido)pentanoyl)glycine; 2-((S)-5-amino-2-((S)-1-((2R,5S,8S,11S,14R)-5-(2-amino-2-oxoethyl)-11-((S)-sec-butyl)-14-(4-ethoxybenzyl)-8-((R)-1-hydroxyethyl)-18-mercapto-2-(mercaptomethyl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oyl)pyrrolidine-2-carboxamido)pentanamido)acetic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More